Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancer

被引：0
|
作者：
Xu, Rui-hua
He, Ming-ming
Zhang, Dong-sheng
Wang, Feng
Jin, Ying
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4049
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer
    Mirtsching, Barry
    Cosgriff, Thomas
    Harker, Graydon
    Keaton, Mark
    Chidiac, Tarek
    Min, Myo
    CLINICAL BREAST CANCER, 2011, 11 (02) : 121 - 128
  • [42] Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
    X. Wang
    M. L. Wang
    L. Y. Zhou
    X. Y. Lu
    J. F. Yang
    H. G. Yu
    Clinical and Translational Oncology, 2013, 15 : 836 - 842
  • [43] A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer
    Jae Jin Lee
    Si-Young Kim
    Hyun-Cheol Chung
    Kyung-Hee Lee
    Hong-Suk Song
    Won-Ki Kang
    Young-Seon Hong
    In-Sil Choi
    Young Yeul Lee
    In-Sook Woo
    Jin-Hyuk Choi
    Cancer Chemotherapy and Pharmacology, 2009, 63
  • [44] Biweekly S-1 and nab-paclitaxel as first-line chemotherapy in patients with unresectable or recurrent gastric cancer
    Yang, L.
    Song, Y.
    Zhang, W.
    Zhou, A.
    Huang, J.
    Jin, W. Wang
    ANNALS OF ONCOLOGY, 2016, 27 : 50 - 51
  • [45] A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer
    Lee, Jae Jin
    Kim, Si-Young
    Chung, Hyun-Cheol
    Lee, Kyung-Hee
    Song, Hong-Suk
    Kang, Won-Ki
    Hong, Young-Seon
    Choi, In-Sil
    Lee, Young Yeul
    Woo, In-Sook
    Choi, Jin-Hyuk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1083 - 1090
  • [46] Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
    Wang, X.
    Wang, M. L.
    Zhou, L. Y.
    Lu, X. Y.
    Yang, J. F.
    Yu, H. G.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (10): : 836 - 842
  • [47] A phase II study of S-1 and irinotecan combination chemotherapy in patients with advanced gastric cancer as a first-line therapy
    Ryoo, B. Y.
    Kang, H. J.
    Yang, S. H.
    Cho, S. H.
    Oh, S. J.
    Lee, M. H.
    Song, E. K.
    Chung, H. C.
    EJC SUPPLEMENTS, 2007, 5 (04): : 274 - 274
  • [48] A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer
    Li, Ning
    Wu, Hui
    Xu, Xin
    Wei, Qinming
    Ding, Yongfeng
    Liu, Shan
    Wu, Jinqiong
    Zheng, Yulong
    Xu, Nong
    Gao, Yuan
    Jiang, Haiping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [49] Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?
    Palumbo, Raffaella
    Sottotetti, Federico
    Bernardo, Antonio
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (03) : 209 - 229
  • [50] Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer
    Yang, Tingsong
    Shen, Xiaojun
    Tang, Xiaojun
    Wei, Guo
    Zhang, Hao
    Du, Chenghui
    Xue, Xuchao
    Ma, Liye
    Nie, Mingming
    Bi, Jianwei
    TUMORI, 2011, 97 (04) : 466 - 472
12345